Article Versions Notes

Koch N, Bourcy Q, Jennotte O, Chiap P, Lechanteur A, Cardot J-M, Evrard B. Selection of In Vivo Relevant Dissolution Test Parameters for the Development of Cannabidiol Formulations with Enhanced Oral Bioavailability. Pharmaceutics. 2025; 17(1):79. https://doi.org/10.3390/pharmaceutics17010079

Koch, Nathan, Quentin Bourcy, Olivier Jennotte, Patrice Chiap, Anna Lechanteur, Jean-Michel Cardot, and Brigitte Evrard. 2025. "Selection of In Vivo Relevant Dissolution Test Parameters for the Development of Cannabidiol Formulations with Enhanced Oral Bioavailability" Pharmaceutics 17, no. 1: 79. https://doi.org/10.3390/pharmaceutics17010079

Koch, N., Bourcy, Q., Jennotte, O., Chiap, P., Lechanteur, A., Cardot, J.-M., & Evrard, B. (2025). Selection of In Vivo Relevant Dissolution Test Parameters for the Development of Cannabidiol Formulations with Enhanced Oral Bioavailability. Pharmaceutics, 17(1), 79. https://doi.org/10.3390/pharmaceutics17010079